Data / Medical devices / United States / Theratest Laboratories, Inc.
Theratest Laboratories, Inc.: FDA-registered device maker in Lombard, IL, United States, 14 510(k) clearances
Theratest Laboratories, Inc. is registered with the FDA (registration 1421346) in Lombard, IL, United States. It lists 14 device types. The FDA files 14 510(k) clearances under its listings, the newest dated March 5, 2010. 4 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 1421346
- Address
- 1120 N Du Page Ave, Lombard, IL, United States, 60148
- Owner or operator
- TheraTest Labs, Inc. (1421346)
- Roles
- Manufacturer
- First device listed
- February 5, 2007
- Registered through
- 2026
- Brand names listed
- EL-ANA Profiles: ANA scr, EL-ANA Profiles: ANA/6, EL-ANA Profiles: ANA/7, EL-ANA Profiles: ANA/8, EL-ANA Profiles: ANA/9, EL-ANA Profiles: anti-Centromere, EL-ANA Profiles: anti-Chromatin, EL-ANA Profiles: anti-Histone and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| March 5, 2010 | K090753 | THERATEST EL-ANTI-CCP/2 | NHX | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| October 9, 2009 | K092757 | THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCR | MSV | Substantially Equivalent | Thera-Test Laboratories, Inc. | accessdata.fda.gov |
| September 3, 2009 | K090760 | THERATEST EL-ANTI-TPO AND THERATEST EL-ANTI-THYROGLOBULIN, MODEL 104-119, 103-120 | JZO | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| November 5, 2007 | K071692 | THERATEST EL-TTG IGA/IGG AND THERATEST EL-GLIA IGA/IGG TEST SYSTEMS | MVM | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| July 20, 2006 | K061376 | EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3 | MOB | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| February 7, 2006 | K060176 | EL-ACL SCREEN; EL-ACL IGM, IGG, IGA | MID | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| October 7, 2005 | K051066 | THERATEST EL-ANA PROFILES | LKP | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| March 11, 2004 | K040291 | EL-ANA PROFILES: ANTI-CHROMATIN | LJM | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| February 6, 2003 | K024151 | EL-ANA PROFILES: ANTI-RIBOSOMAL PROTEIN P | MQA | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| February 6, 2003 | K024031 | THE THERATEST EL-ANA PROFILES: ANTI-CENTROMERE | LJM | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| March 6, 1996 | K955481 | THERATEST KIT (MODIFICATION) | LJM | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| November 14, 1995 | K954106 | THERATEST LAB, INC., EL-ANASCR KIT | LJM | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| July 28, 1995 | K941398 | EL-RF/3 (IGM-IGG-IGA) KIT | DHR | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
| January 28, 1994 | K933712 | EL-RF TEST SYSTEM: EL-RF-IGM KIT | DHR | Substantially Equivalent | Theratest Laboratories, Inc. | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| October 5, 2020 | 88478 | Class II | Terminated | EL-Anti-SARS-CoV-2 IgG Kit, Catalog #. Submitted as EUA202128 | The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128 | accessdata.fda.gov |
| July 30, 2020 | 88477 | Class II | Terminated | EL-Anti-SARS-CoV-2 IgM Kit, Catalog #, IVD. Submitted as EUA202129 | Device did not meet the updated EUA packet requirements for positive percent agreement, thus, not adequately validated. Submitted as EUA202129 | accessdata.fda.gov |
| March 29, 2012 | 61500 | Not yet classified | Terminated | RF IgA Calibrator, a component of the EL-RF/3 Rheumatoid Factor Test Kit; an in vitro diagnostic; TheraTest Laboratories, Lombard, IL 60148; component catalog #12833, kit catalog #. The TheraTest EL-RF/3 is intended as a | The RF IgA Calibrator component of the EL-RF/3 Rheumatoid Factor test system may be unstable, resulting in a drop in the RF IgA calibrator OD value which could invalidate an RF IgA test run. | accessdata.fda.gov |
| January 11, 2006 | 34945 | Not yet classified | Terminated | EL-aCL Anti-Cardiolipin ELISA Kit; an in-vitro diagnostic anticardiolipin immunological test system; 192 tests per kit; catalog #; Thera Test Laboratories Inc., 1111 North Main Street, Lombard, IL 60148 | The specimen diluent contained in the kits was contaminated with a fungal growth. Also, a portion of kit lot 09055514 was shipped without the Data Sheet, part #. | accessdata.fda.gov |
Compare with other makers
- All makers of Antibodies, Gliadin
- All makers of Autoantibodies, Endomysial(Tissue Transglutaminase)
- All makers of Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
- All makers of System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
- All makers of System, Test, Anticardiolipin Immunological
- All makers of System, Test, Rheumatoid Factor
Updated March 5, 2010. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.